Cargando…
PD-L1 expression in perihilar and intrahepatic cholangiocarcinoma
Cholangiocarcinoma is an aggressive biliary neoplasm lacking effective therapeutic agents. Immunotherapies targeting the PD-L1/PD-1 immune checkpoint have shown encouraging results in solid and hematologic cancers in clinical trials. Response to these immunomodulators is correlated with PD-L1 expres...
Autores principales: | Fontugne, Jacqueline, Augustin, Jérémy, Pujals, Anaïs, Compagnon, Philippe, Rousseau, Benoit, Luciani, Alain, Tournigand, Christophe, Cherqui, Daniel, Azoulay, Daniel, Pawlotsky, Jean-Michel, Calderaro, Julien |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5421876/ https://www.ncbi.nlm.nih.gov/pubmed/28445951 http://dx.doi.org/10.18632/oncotarget.15602 |
Ejemplares similares
-
The prognostic impact of preoperative body composition in perihilar and intrahepatic cholangiocarcinoma
por: Lurje, Isabella, et al.
Publicado: (2022) -
Targeted Therapies for Perihilar Cholangiocarcinoma
por: Gray, Simon, et al.
Publicado: (2022) -
Vascular Resection in Perihilar Cholangiocarcinoma
por: Serrablo, Alejandro, et al.
Publicado: (2021) -
Preoperative Management of Perihilar Cholangiocarcinoma
por: Ellis, Ryan J., et al.
Publicado: (2022) -
Neoadjuvant Chemotherapy for Intrahepatic, Perihilar, and Distal Cholangiocarcinoma: a National Population-Based Comparative Cohort Study
por: Parente, Alessandro, et al.
Publicado: (2023)